GlassScriptPhysician profile
Holly J Meany
NPI 1194810325
$23,329.63
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,211 · 2023: $16K · 2024: $1,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Consulting Fee: $4,025 · Food and Beverage: $93.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,000.00 |
| Consulting Fee | $4,025.00 |
| Food and Beverage | $93.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $14,037.31 | 2023-2024 | Iwilfin |
| Y-Mabs Therapeutics, INC. | $7,451.00 | 2022-2023 | Danyelza |
| Bayer Healthcare Pharmaceuticals INC. | $1,785.00 | 2024 | |
| Fennec Pharmaceuticals, INC. | $31.87 | 2023 | Pedmark |
| Novartis Pharmaceuticals Corporation | $24.45 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Meany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.